Progyny Future Growth
Future criteria checks 4/6
Progyny is forecast to grow earnings and revenue by 22.9% and 15.9% per annum respectively. EPS is expected to grow by 20.7% per annum. Return on equity is forecast to be 20% in 3 years.
Key information
22.9%
Earnings growth rate
20.7%
EPS growth rate
| Healthcare earnings growth | 17.3% |
| Revenue growth rate | 15.9% |
| Future return on equity | 20.0% |
| Analyst coverage | Good |
| Last updated | 02 May 2024 |
Recent future growth updates
Recent updates
Why We're Not Concerned About Progyny, Inc.'s (NASDAQ:PGNY) Share Price
Apr 29
Is Now An Opportune Moment To Examine Progyny, Inc. (NASDAQ:PGNY)?
Apr 03Progyny: Long-Term Outlook Remains Positive, Reiterate Buy
Mar 15Progyny: Long-Term Thesis Still Intact
Mar 09Progyny's (NASDAQ:PGNY) Returns On Capital Are Heading Higher
Mar 01Progyny, Inc.'s (NASDAQ:PGNY) P/E Still Appears To Be Reasonable
Jan 07Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?
Dec 11Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)
Nov 08Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?
Aug 24There's Been No Shortage Of Growth Recently For Progyny's (NASDAQ:PGNY) Returns On Capital
Aug 06Progyny (NASDAQ:PGNY) Is Looking To Continue Growing Its Returns On Capital
May 06When Should You Buy Progyny, Inc. (NASDAQ:PGNY)?
Jan 25Progyny (NASDAQ:PGNY) Shareholders Will Want The ROCE Trajectory To Continue
Dec 12Is It Time To Consider Buying Progyny, Inc. (NASDAQ:PGNY)?
Oct 18Progyny Stock Should Deliver Superior Returns For Investors
Aug 05Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)
Jul 27At US$31.63, Is Progyny, Inc. (NASDAQ:PGNY) Worth Looking At Closely?
Jul 08Progyny: Solving Infertility Problem
Jul 05Progyny Stock: A Hidden Gem Tackling Infertility
May 31Investors Will Want Progyny's (NASDAQ:PGNY) Growth In ROCE To Persist
Apr 18At US$50.90, Is It Time To Put Progyny, Inc. (NASDAQ:PGNY) On Your Watch List?
Mar 31Earnings Not Telling The Story For Progyny, Inc. (NASDAQ:PGNY)
Mar 18Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,872 | 127 | 280 | 286 | 3 |
| 12/31/2025 | 1,565 | 105 | 220 | 224 | 9 |
| 12/31/2024 | 1,299 | 70 | 172 | 172 | 9 |
| 12/31/2023 | 1,089 | 62 | 185 | 189 | N/A |
| 9/30/2023 | 1,033 | 52 | 199 | 203 | N/A |
| 6/30/2023 | 957 | 49 | 165 | 169 | N/A |
| 3/31/2023 | 873 | 43 | 109 | 113 | N/A |
| 12/31/2022 | 787 | 30 | 77 | 80 | N/A |
| 9/30/2022 | 700 | 42 | 35 | 38 | N/A |
| 6/30/2022 | 617 | 46 | 38 | 41 | N/A |
| 3/31/2022 | 551 | 56 | 12 | 14 | N/A |
| 12/31/2021 | 501 | 66 | 24 | 26 | N/A |
| 9/30/2021 | 473 | 90 | 22 | 24 | N/A |
| 6/30/2021 | 450 | 78 | 14 | 15 | N/A |
| 3/31/2021 | 386 | 58 | 24 | 25 | N/A |
| 12/31/2020 | 345 | 46 | 35 | 36 | N/A |
| 9/30/2020 | 310 | 3 | 21 | 24 | N/A |
| 6/30/2020 | 272 | -10 | 11 | 15 | N/A |
| 3/31/2020 | 264 | -5 | 13 | 17 | N/A |
| 12/31/2019 | 230 | -9 | -4 | -2 | N/A |
| 9/30/2019 | 194 | -6 | 7 | 8 | N/A |
| 6/30/2019 | 160 | 1 | 1 | 2 | N/A |
| 3/31/2019 | 130 | -4 | 0 | 0 | N/A |
| 12/31/2018 | 105 | -6 | 2 | 2 | N/A |
| 12/31/2017 | 49 | -13 | -10 | -9 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PGNY's forecast earnings growth (22.9% per year) is above the savings rate (2.4%).
Earnings vs Market: PGNY's earnings (22.9% per year) are forecast to grow faster than the US market (14.1% per year).
High Growth Earnings: PGNY's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: PGNY's revenue (15.9% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: PGNY's revenue (15.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PGNY's Return on Equity is forecast to be low in 3 years time (20%).